Siga Technologies (SIGA) Competitors $8.25 -0.24 (-2.83%) Closing price 08/27/2025 04:00 PM EasternExtended Trading$8.20 -0.05 (-0.67%) As of 08/27/2025 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SIGA vs. GMTX, CPRX, ALVO, KNSA, OGN, TARS, CNTA, DNLI, AGIO, and IDYAShould you be buying Siga Technologies stock or one of its competitors? The main competitors of Siga Technologies include Gemini Therapeutics (GMTX), Catalyst Pharmaceuticals (CPRX), Alvotech (ALVO), Kiniksa Pharmaceuticals International (KNSA), Organon & Co. (OGN), Tarsus Pharmaceuticals (TARS), Centessa Pharmaceuticals (CNTA), Denali Therapeutics (DNLI), Agios Pharmaceuticals (AGIO), and IDEAYA Biosciences (IDYA). These companies are all part of the "pharmaceutical products" industry. Siga Technologies vs. Its Competitors Gemini Therapeutics Catalyst Pharmaceuticals Alvotech Kiniksa Pharmaceuticals International Organon & Co. Tarsus Pharmaceuticals Centessa Pharmaceuticals Denali Therapeutics Agios Pharmaceuticals IDEAYA Biosciences Gemini Therapeutics (NASDAQ:GMTX) and Siga Technologies (NASDAQ:SIGA) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations, media sentiment and dividends. Do institutionals & insiders believe in GMTX or SIGA? 75.4% of Gemini Therapeutics shares are owned by institutional investors. Comparatively, 55.4% of Siga Technologies shares are owned by institutional investors. 12.9% of Gemini Therapeutics shares are owned by company insiders. Comparatively, 2.0% of Siga Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is GMTX or SIGA more profitable? Siga Technologies has a net margin of 45.73% compared to Gemini Therapeutics' net margin of 0.00%. Siga Technologies' return on equity of 40.52% beat Gemini Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Gemini TherapeuticsN/A -38.78% -35.88% Siga Technologies 45.73%40.52%35.62% Which has more risk and volatility, GMTX or SIGA? Gemini Therapeutics has a beta of -0.12, meaning that its share price is 112% less volatile than the S&P 500. Comparatively, Siga Technologies has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500. Does the media prefer GMTX or SIGA? In the previous week, Siga Technologies had 4 more articles in the media than Gemini Therapeutics. MarketBeat recorded 4 mentions for Siga Technologies and 0 mentions for Gemini Therapeutics. Siga Technologies' average media sentiment score of 1.01 beat Gemini Therapeutics' score of 0.00 indicating that Siga Technologies is being referred to more favorably in the news media. Company Overall Sentiment Gemini Therapeutics Neutral Siga Technologies Positive Which has higher earnings & valuation, GMTX or SIGA? Siga Technologies has higher revenue and earnings than Gemini Therapeutics. Gemini Therapeutics is trading at a lower price-to-earnings ratio than Siga Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGemini TherapeuticsN/AN/A-$71.87M-$1.00-59.79Siga Technologies$138.72M4.26$59.21M$1.137.30 SummarySiga Technologies beats Gemini Therapeutics on 10 of the 12 factors compared between the two stocks. Get Siga Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SIGA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SIGA vs. The Competition Export to ExcelMetricSiga TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$607.93M$2.51B$5.76B$9.78BDividend YieldN/A1.69%3.95%4.03%P/E Ratio7.3022.5330.8526.37Price / Sales4.26739.53471.21121.78Price / Cash10.15177.7737.7659.36Price / Book2.836.2910.136.62Net Income$59.21M$32.94M$3.26B$265.42M7 Day Performance-5.71%1.13%2.86%3.15%1 Month Performance14.42%1.52%4.02%0.82%1 Year Performance-10.42%11.43%43.37%22.99% Siga Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIGASiga Technologies2.1429 of 5 stars$8.25-2.8%N/A-11.6%$607.93M$138.72M7.3040GMTXGemini TherapeuticsN/A$60.35+1.0%N/A+20.2%$2.61BN/A-60.3530CPRXCatalyst Pharmaceuticals4.893 of 5 stars$20.62-2.2%$33.20+61.0%-1.4%$2.58B$491.73M12.5080Positive NewsGap UpALVOAlvotech2.1566 of 5 stars$8.32-1.5%$14.00+68.3%-31.5%$2.55B$491.98M36.171,032KNSAKiniksa Pharmaceuticals International2.3914 of 5 stars$33.04-2.1%$41.17+24.6%+24.5%$2.50B$423.24M826.21220OGNOrganon & Co.4.8069 of 5 stars$9.08-3.8%$18.00+98.3%-58.9%$2.45B$6.40B3.374,000Positive NewsTARSTarsus Pharmaceuticals1.8239 of 5 stars$56.61-1.1%$66.67+17.8%+114.2%$2.42B$182.95M-24.3050Positive NewsCNTACentessa Pharmaceuticals2.2841 of 5 stars$17.00-0.1%$28.10+65.3%+23.3%$2.28B$6.85M-9.50200Positive NewsDNLIDenali Therapeutics4.3188 of 5 stars$15.57+0.5%$33.62+115.9%-37.5%$2.26B$330.53M-5.56430Positive NewsAGIOAgios Pharmaceuticals4.3754 of 5 stars$37.26-4.0%$56.33+51.2%-16.6%$2.25B$36.50M3.39390Positive NewsIDYAIDEAYA Biosciences4.4489 of 5 stars$24.71-1.6%$48.09+94.6%-36.5%$2.20B$7M-6.5280News CoveragePositive News Related Companies and Tools Related Companies Gemini Therapeutics Alternatives Catalyst Pharmaceuticals Alternatives Alvotech Alternatives Kiniksa Pharmaceuticals International Alternatives Organon & Co. Alternatives Tarsus Pharmaceuticals Alternatives Centessa Pharmaceuticals Alternatives Denali Therapeutics Alternatives Agios Pharmaceuticals Alternatives IDEAYA Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SIGA) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Siga Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Siga Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access